No Record Found
Sector
PharmaceuticalsOpen
₹92.59Prev. Close
₹92.53Turnover(Lac.)
₹1,259.03Day's High
₹95.65Day's Low
₹92.3552 Week's High
₹126.6652 Week's Low
₹57.5Book Value
₹58.64Face Value
₹2Mkt Cap (₹ Cr.)
2,773.25P/E
26.27EPS
3.59Divi. Yield
0.85No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
Equity Capital  | 58.71  | 58.71  | 58.71  | 58.71  | 
Preference Capital  | 0  | 0  | 0  | 0  | 
Reserves  | 1,628.7  | 1,552.62  | 1,447.84  | 1,331.56  | 
Net Worth  | 1,687.41  | 1,611.33  | 1,506.55  | 1,390.27  | 
Minority Interest  | 
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Revenue  | 2,184.02  | 1,966.98  | 1,894.47  | 983.3  | 
yoy growth (%)  | 11.03  | 3.82  | 92.66  | 38.36  | 
Raw materials  | -1,570.51  | -1,102.84  | -1,065.01  | -695.28  | 
As % of sales  | 71.9  | 56.06  | 56.21  | 70.7  | 
Employee costs  | -141.3  | -115.55  | -97.2  | -56.1  | 
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Profit before tax  | 236.77  | 571.39  | 533.24  | 31.3  | 
Depreciation  | -43.26  | -38.92  | -35.73  | -30.21  | 
Tax paid  | -57.18  | -126.83  | -171.95  | -3.6  | 
Working capital  | -112.32  | 268.04  | 207.28  | -4.75  | 
Other operating items  | 
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Growth matrix (%)  | ||||
Revenue growth  | 11.03  | 3.82  | 92.66  | 38.36  | 
Op profit growth  | -56.69  | 3.12  | 362.95  | 21.29  | 
EBIT growth  | -57.54  | 4.15  | 479.37  | 29.94  | 
Net profit growth  | -62.73  | 23.04  | 1,204.29  | 493.14  | 
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | 
|---|---|---|---|---|
Gross Sales  | 2,079.21  | 2,132.79  | 2,217.11  | 2,184.02  | 
Excise Duty  | 0  | 0  | 0  | 0  | 
Net Sales  | 2,079.21  | 2,132.79  | 2,217.11  | 2,184.02  | 
Other Operating Income  | 0  | 0  | 0  | 0  | 
Other Income  | 22.41  | 30.07  | 25.61  | 32.04  | 
Company Name  | LTP (₹)  | P/E  (%)  | Mkt.Cap  (₹Cr.)  | NP Qtr (₹Cr.)  | Div.Yield  (%)  | Sales Qtr  (₹.Cr)  | Book Value (₹)  | 
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA  | 1,690.7  | 81.4 | 4,05,451.62 | 753.53 | 0.95 | 5,566.68 | 101.44 | 
Divis Laboratories Ltd DIVISLAB  | 6,738  | 76.66 | 1,79,089.09 | 557 | 0.44 | 2,357 | 561.08 | 
Cipla Ltd CIPLA  | 1,501.3  | 23.34 | 1,21,298.96 | 1,210.53 | 1.07 | 4,495.16 | 411.56 | 
Torrent Pharmaceuticals Ltd TORNTPHARM  | 3,560.1  | 60.59 | 1,20,450.71 | 551 | 0.17 | 2,567 | 224.34 | 
Dr Reddys Laboratories Ltd DRREDDY  | 1,197.6  | 18.52 | 99,965.86 | 387.3 | 0.67 | 4,602.9 | 377.57 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Varinder Gupta
Joint Managing Director
Vikas Gupta
Chairman & Independent Director
Rajender Mohan Malla
Independent Director
Harpal Singh
Company Sec. & Compli. Officer
Abhay Raj Singh
Director (Works)
Kushal Kumar Rana
Independent Director
SHARAD TYAGI
Executive Director
Abhiraj Gupta
Independent Director
Rajni Jha
Trident Complex,
Raikot Road Barnala,
Punjab - 148101
Tel: 91-01679-244701-07
Website: http://www.iolcp.com
Email: investor@iolcp.com; contact@iolcp.com
A-40 II Flr Phase-II,
Naraina Indl Area, Near Batra Banquet,
New Delhi - 110 028
Tel: 91-11-41410592/93/94
Website: www.linktime.co.in
Email: delhi@linkintime.co.in
Summary
IOL Chemicals and Pharmaceuticals Limited, incorporated in September, 1986 is a renowned company in the Active PharmaceuticalIngredient (API) and specialty chemicals sectors. Its extensive expertise i...
Read More
Reports by IOL Chemicals & Pharmaceuticals Ltd
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.